The new drug has been developed by researchers at Australia’s Griffith University to target and reverse the sepsis, rather ...

New study into the molecular pathways involved in sepsis is one step closer to rapid and targeted treatment of patients. New study into the molecular pathways involved in sepsis is one step closer to ...

Sepsis kills more than a quarter of a million people each year, but early signs of the condition are not nearly as well known among the public as the early signs for other conditions — a problem ...

CCO Hoda Asmar says the health system improved sepsis care during the first two years by focusing on two processes, including early administration of antibiotics. After committing to improve sepsis ...